| 書目名稱 | Lifelong Management of Hypertension |
| 編輯 | H. Mitchell Perry (Physician Coordinator for Hyper |
| 視頻video | http://file.papertrans.cn/586/585946/585946.mp4 |
| 叢書名稱 | Developments in Cardiovascular Medicine |
| 圖書封面 |  |
| 描述 | In the thirty years since the advent of efTective pharmacologic treatment for hypertension, the world ofthe hypertensive has been transformed beyond recog- nition. The first change involved only malignant hypertensives with enough residual renal parenchyma to survive. Such a hypertensive could trade inevitable renal failure - unless an intracerebral bleed occurred first - for a rigid regimen which prevented his blood pressure from destroying him but which was asso- ciated with nearly intolerable side effects. Over the next 20 years, increasing numbers of patients with hypertension of decreasing severity were treated with drugs that had fewer and fewer side effects. In 1970, with the medical world finally ready to accept the concept, the well-known Veterans Administration Study demonstrated that morbidity and mortality could be diminished in mode- rately hypertensive patients by antihypertensive therapy that had minimal side effects. As a result there has been a major attempt to bring everyone with elevated blood pressure under lifelong pharmacologic control. It is difficult, however, to know what levels ofblood pressure deserve treatment; many who, when therapy first became availab |
| 出版日期 | Book 1983 |
| 關鍵詞 | drugs; heart; heart failure; hypertension; platelet |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-94-009-6732-8 |
| isbn_softcover | 978-94-009-6734-2 |
| isbn_ebook | 978-94-009-6732-8Series ISSN 0166-9842 |
| issn_series | 0166-9842 |
| copyright | Martinus Nijhoff Publishers, Boston 1983 |
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-7 11:19
發(fā)表于 2025-3-21 16:39:18
